ADVERTISEMENT

Taming the Beast

Krysti Hughett shares her experience as a breast cancer survivor and advocate.  

BY KATHY LATOUR
PUBLISHED SUNDAY, DECEMBER 6, 2009
Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
Krysti Hughett listens intently to the woman on the other end of the phone. From her side of the conversation, it’s clear—there is one more breast cancer survivor now living in Hughett’s home city of Indianapolis, Indiana. She reassures the woman and then offers to have someone from the Young Survival Coalition office, where Hughett is a resource specialist, to go with the woman to the doctor.

It’s a 24/7 job for Hughett, and one she embraces with the enthusiasm of a zealot despite dealing with her own ongoing treatment for lung metastases. Diagnosed with stage 4 bilateral inflammatory breast cancer in March 2005, Hughett, 45, was told, until the day she was diagnosed, that the rash on both her breasts was not breast cancer. It made sense to Hughett, who was convinced that the rash was a reaction to a new feather mattress her husband bought a month before. 

“There was no lump, and a mammogram and sonogram three days before diagnosis showed nothing,” she says. “I was a medical consumer who had followed my breast [exams] since age 20 when I had a benign lump—but I was willing to believe the medical professionals.” 

It was a young family internist who prompted Hughett to push for a diagnosis, setting her up with a surgeon while eight core biopsies were being analyzed. Hughett says the surgeon didn’t think it was breast cancer, but conceded that he had no idea what he was looking at and suggested she go to his mentor and teacher Robert Goulet, MD, at the Indiana University Melvin and Bren Simon Cancer Center. 

“Dr. Goulet knew by looking at it that it was inflammatory breast cancer,” Hughett says. 

From there things moved quickly. After four weeks of chemotherapy, Hughett had a bilateral mastectomy. The cancer continued to confound doctors by coming back as triple negative, and then showing as HER2-positive in later pathology. Scans also showed multiple spots on her lungs, meaning the cancer was stage 4. 

It was a shock for Hughett, the mother of three daughters—the youngest only 6. 

She immediately began preoperative chemotherapy, and had a rush, she says, when she realized she was sitting in the same chemo chair that Lance Armstrong used when he got his chemo from Lawrence Einhorn, MD, at Indiana University. Then she began researching her condition. 

“Two weeks after surgery, I met Ginny Mason, the executive director of the Inflammatory Breast Cancer Research Foundation, who was doing a meeting in Indianapolis,” Hughett says. “I walked in and met all these inflammatory women, and it was amazing.” 

Hughett says she dived right into the information, saying her motto has always been, “better the beast I know than the one I don’t.” 

Since then Hughett has advocated for herself by seeking out three clinical trials that have kept her lung mets stable. She jokes that she comes to SABCS to shop for her next clinical trial. 

“I am a clinical trial junky,” she says. 

Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
ADVERTISEMENT
ShareYourStory
Related Articles
Pregnancy and a Breast Cancer Diagnosis
BY ELEANOR MILLER
Eleanor Miller, a nurse at the University of Pennsylvania, writes about considerations for a patient who is pregnant with a breast cancer diagnosis.
Understanding the Characteristics and Behavior of Breast Cancer
BY LAURA MARTIN
Advances in molecular profiling technologies have made it easier to understand the molecular characteristics and clinical behavior of breast cancer.
Fear Less
A cancer diagnosis brings with it a world of fears, but living with advanced/terminal cancer puts the other fears into perspective.
Long-Term Cancer Treatment — A Patient’s Perspective
BY AIMEE SHAW
Having been a 12-year cancer survivor, metastatic since 2006, I’ve gained a lot of experience with what long-term palliative care looks and feels like.
I'm Going to Live Until I Die
Don't go to the funeral until the day of the funeral.
Related Videos
Jennifer Klemp on Survivorship for Patients With Hereditary Breast Cancer
BY JENNIFER KLEMP, PHD, MPH
Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses survivorship for patients with hereditary breast cancer.
Jennifer Klemp Discusses Breast Cancer Survivorship
BY JENNIFER KLEMP, PHD, MPH
Jennifer Klemp, PhD, MPH, director, Breast Cancer Survivorship Center, The University of Kansas Cancer Center, discusses breast cancer survivorship.
Debu Tripathy Discusses a Clinical Trial of Ibrance in Breast Cancer
BY DEBU TRIPATHY
Debu Tripathy, editor-in-chief of CURE and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses adding the targeted drug Ibrance to the hormonal drug Faslodex.
Health Advocate Amy Byer Shainman Discusses Risk Management of Hereditary Cancers
When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.
Research Updates on HER2-Positive Breast Cancer from the 2015 Miami Breast Cancer Conference
Debu Tripathy, editor-in-chief of CURE magazine, discusses updates from the Miami Breast Cancer Conference, including the changing landscape of HER2-positive breast cancer.
$auto_registration$